Grown Rogue International Inc. Share Price OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4584 USD | +2.57% |
|
+14.57% | -11.15% |
| 13/05 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 13/05 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 11Cr 9.88Cr 9.11Cr 8.42Cr 16Cr 1.08TCr 16Cr 108.96Cr 43Cr 529.89Cr 42Cr 41Cr 1.83TCr | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 10Cr 9.56Cr 18Cr 1.22TCr 18Cr 123.73Cr 49Cr 601.69Cr 48Cr 47Cr 2.08TCr | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +2.57% | ||
| 1 week | +14.57% | ||
| Current month | -0.02% | ||
| 1 month | -4.50% | ||
| 3 months | +55.97% | ||
| 6 months | +6.11% | ||
| Current year | -11.15% |
| 1 week | 0.43 | 0.49 | |
| 1 month | 0.38 | 0.49 | |
| Current year | 0.27 | 0.52 | |
| 1 year | 0.27 | 0.52 | |
| 3 years | 0.16 | 0.9 | |
| 5 years | 0.02 | 0.9 | |
| 10 years | 0 | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.57% | +14.57% | - | - | 11Cr | ||
| -0.64% | +0.81% | -13.58% | -7.04% | 1.28TCr | ||
| -1.20% | -0.56% | -35.11% | -56.85% | 471.71Cr | ||
| -0.40% | +1.65% | -8.91% | -4.82% | 440.79Cr | ||
| +0.55% | +4.88% | +23.46% | -1.90% | 389.21Cr | ||
| -1.24% | -1.04% | +3.19% | -38.95% | 377.69Cr | ||
| +1.30% | +7.30% | -6.84% | -12.36% | 322.29Cr | ||
| -0.14% | +3.24% | -11.53% | +2.33% | 308.74Cr | ||
| -0.89% | +3.65% | -5.62% | -22.45% | 244.13Cr | ||
| -0.50% | +9.11% | -6.04% | +44.11% | 181.28Cr | ||
| Average | -0.06% | +1.09% | -6.78% | -10.88% | 445.81Cr | |
| Weighted average by Cap. | -0.43% | +0.24% | -8.90% | -13.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.7Cr 2.36Cr 2.18Cr 2.01Cr 3.83Cr 257.69Cr 3.89Cr 26Cr 10Cr 126.79Cr 10Cr 9.92Cr 438.64Cr | 3.24Cr 2.84Cr 2.62Cr 2.42Cr 4.59Cr 309.29Cr 4.67Cr 31Cr 12Cr 152.19Cr 12Cr 12Cr 526.49Cr |
| Net income | -1.13Cr -98.88L -91.19L -84.3L -1.6Cr -107.81Cr -1.63Cr -11Cr -4.28Cr -53Cr -4.24Cr -4.15Cr -183.52Cr | 17.3L 15.13L 13.95L 12.9L 24.51L 16Cr 24.92L 1.67Cr 65.45L 8.12Cr 64.94L 63.53L 28Cr |
| Net Debt | 37.04L 32.4L 29.88L 27.62L 52.49L 35Cr 53.37L 3.57Cr 1.4Cr 17Cr 1.39Cr 1.36Cr 60Cr | 1.53Cr 1.34Cr 1.23Cr 1.14Cr 2.17Cr 145.92Cr 2.2Cr 15Cr 5.79Cr 72Cr 5.74Cr 5.62Cr 248.4Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | $0.4584 | +2.57% | 1,14,400 |
| 08/26/08 | $0.4469 | -2.31% | 2,64,255 |
| 07/26/07 | $0.4575 | -0.55% | 22,222 |
| 06/26/06 | $0.4600 | -0.11% | 1,86,165 |
| 02/26/02 | $0.4605 | +15.10% | 2,28,010 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUSF Stock
Select your edition
All financial news and data tailored to specific country editions

















